Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
10/13/2005 | WO2005094576A2 Cryopreservation media |
10/13/2005 | WO2005094524A2 Cell culture apparatus and methods |
10/13/2005 | WO2005094391A2 METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING DISEASE ASSOCIATED WITH αVβ5 INTEGRIN |
10/13/2005 | WO2005094364A2 Iga antibody protein as a cytotoxic drug |
10/13/2005 | WO2005094353A2 Methods for production of regulatory t cells and uses thereof |
10/13/2005 | WO2005094348A2 Anti-lfl2 antibodies for the diagnosis, prognosis and treatment of cancer |
10/13/2005 | WO2005094324A2 Mixed cell diagnostic systems |
10/13/2005 | WO2005094279A2 Immortalized human tuberous sclerosis null angiomyolipoma cell and method of use thereof |
10/13/2005 | WO2005094267A2 Methods for regulating differentiation of neural cells and uses thereof |
10/13/2005 | WO2005094162A2 Culture and use of cells that secrete liver secretory factors |
10/13/2005 | WO2005070011A3 Improved modalities for the treatment of degenerative diseases of the retina |
10/13/2005 | WO2005063969A3 Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and uses thereof |
10/13/2005 | WO2005060553A8 Geraniol synthase, methods of production and uses thereof |
10/13/2005 | WO2005014788A3 Tssk4: a human testis specific serine/threonine kinase |
10/13/2005 | WO2005012506A3 Extended primary retinal cell culture and stress models, and methods of use |
10/13/2005 | WO2004072253A3 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
10/13/2005 | WO2003099779A3 Hemipteran muscarinic receptor |
10/13/2005 | WO2003088808A3 Compositions and methods for the diagnosis and treatment of tumor |
10/13/2005 | WO2003031643A3 Methods for regulating co-stimulatory molecule expression with reactive oxygen |
10/13/2005 | WO2002014467A9 Cng2b: a putative human cyclic nucleotide-gated ion channel |
10/13/2005 | US20050229271 Compositions and methods for altering amino acid content of proteins |
10/13/2005 | US20050229266 Method for producing non-human mammal RNAi phenotype using papilloma virus vector |
10/13/2005 | US20050229264 Recombinant gelatins |
10/13/2005 | US20050229262 Peptide production |
10/13/2005 | US20050228170 B7-like molecules and uses thereof |
10/13/2005 | US20050227937 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor |
10/13/2005 | US20050227355 Serum-free cell culture media |
10/13/2005 | US20050227354 Using fibronectin nutrient broth to propagate cytotoxic lymphocyte with enhanced interleukin-2 receptor expression profiles; immunotherapy; antitumor agents |
10/13/2005 | US20050227353 Methods of inducing differentiation of stem cells |
10/13/2005 | US20050227352 Use of BMP (BAM) signaling to control stem cell fate determination |
10/13/2005 | US20050227351 Methods and compound protein molecules used for inducing cytotoxic cell-mediated immune response in a mammal against a pathogenic cell |
10/13/2005 | US20050227344 Mixture obtained from penicillium funiculosu |
10/13/2005 | US20050227328 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/13/2005 | US20050227325 Recombinant polynucleotide |
10/13/2005 | US20050227324 Comprise a single antigen binding arm and an Fc region; exhibits enhanced stability in vivo compared to a Fab antibody fragment |
10/13/2005 | US20050227319 DNA sequences coding for enzymes capable of facilitating the synthesis of linear alpha-1,4 glucans in plants, fungi and microorganisms |
10/13/2005 | US20050227317 Mammalian expression system |
10/13/2005 | US20050227289 Antibodies to erythropoietin receptor and uses thereof |
10/13/2005 | US20050227287 Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPSc |
10/13/2005 | US20050227285 Control of gene expression in eukaryotic cells |
10/13/2005 | US20050227282 Human extracellular matrix-1 |
10/13/2005 | US20050227280 Proteases |
10/13/2005 | US20050227277 Apoptosis proteins |
10/13/2005 | US20050227262 polynucleotides that code for polypeptide comprising beta-ketoacyl synthase, acetyl transferase, dehydratase, methyltransferase, ketoreductase, and acyl carrier proteins; anticholesterol agents produced by Monascus |
10/13/2005 | US20050227249 Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications |
10/13/2005 | US20050227245 Reagents and methods for identifying and modulating expression of genes regulated by retinoids |
10/13/2005 | US20050227226 Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease |
10/13/2005 | US20050227219 Method for suppression or reversing of cellular aging |
10/13/2005 | US20050226885 Cytolysis of target cells by superantigen conjugates inducing T-cell activation |
10/13/2005 | US20050226879 Methods and compositions related to inhibiting nuclear envelope breakdown |
10/13/2005 | US20050226866 Bone morphogenic protein specific immunoglobulin for treatment of bone diseases; immunotherapy |
10/13/2005 | US20050226865 Methods and compositions for treating and preventing diseases associated with alphavbeta5 integrin |
10/13/2005 | US20050226857 T cell therapy for the treatment of cachexia and chronic diseases |
10/13/2005 | US20050226855 Transformation of pluripotential stem cells for tissue repain, replacement in organs such as heart, brain, liver, kidney or pancreas; supplying cells using catheters |
10/13/2005 | US20050226854 treating a renal, hepatic or enzyme-deficiency disorder in a subject in need thereof by transplanting into the subject tissue derived from a human or porcine kidney or liver, the kidney or liver being at a selected gestational stage |
10/13/2005 | US20050226853 Skin substitutes and uses thereof |
10/13/2005 | US20050226852 Method of inducing growth of nerve stem cells |
10/13/2005 | US20050226848 Transcriptional regulation of gene expression by small double-stranded modulatory RNA |
10/13/2005 | DE60104282T2 Lösliche mutante ctla4 moleküle und deren verwendung Soluble CTLA4 mutant molecules and their use |
10/13/2005 | DE10031851B4 Photodynamische Behandlung und UV-B-Bestrahlung einer Thrombozyten-Suspension Photodynamic treatment and UV-B irradiation of a platelet suspension |
10/13/2005 | CA2847454A1 Method for modification of nmda receptors through inhibition of src |
10/13/2005 | CA2566374A1 Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells, and the method of macromass culture |
10/13/2005 | CA2562953A1 Humanized and chimeric anti-osm antibodies |
10/13/2005 | CA2562038A1 Methods and compositions for treating and preventing disease associated with .alpha.v.beta.5 integrin |
10/13/2005 | CA2561725A1 Culture and use of cells that secrete liver secretory factors |
10/13/2005 | CA2561702A1 Methods for altering protein production rates |
10/13/2005 | CA2561681A1 Use of a composition which regulates oxidation/reduction reactions intracellularly and/or extracellularly in a staining or sorting process of spermatozoa |
10/13/2005 | CA2561661A1 Sperm suspensions for sorting into x or y chromosome-bearing enriched populations |
10/13/2005 | CA2561519A1 Sperm dispersions for use in insemination |
10/13/2005 | CA2561405A1 Monoclonal antibodies to gastrin hormone |
10/13/2005 | CA2561376A1 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins |
10/13/2005 | CA2560944A1 Arabinogalactan protein compositions and methods for fostering somatic embryogenic competence |
10/13/2005 | CA2560618A1 A cell culture system for modelling serum amyloid a amyloidogenesis and identifying amyloid modulating compounds |
10/13/2005 | CA2560052A1 Cell carrier and cell carrier containment devices containing regenerative cells |
10/13/2005 | CA2560011A1 Cospeptin, cosmedin and their uses |
10/13/2005 | CA2559865A1 Preparation of a cell concentrate from a physiological solution |
10/13/2005 | CA2559827A1 Filamentous fungal mutants with improved homologous recombination efficiency |
10/13/2005 | CA2557843A1 Plants with reduced activity of the starch phosphorylating enzyme phosphoglucan, water dikinase |
10/13/2005 | CA2557673A1 Cryopreservation media |
10/13/2005 | CA2557046A1 Process for cell culturing by continuous perfusion and alternating tangential flow |
10/13/2005 | CA2545512A1 Methods of identifying neoplasm-specific antibodies and uses thereof |
10/12/2005 | EP1584686A1 Progenitor cell preservation factors and related methods and products |
10/12/2005 | EP1584683A1 Human orphan g protein-coupled receptors |
10/12/2005 | EP1584678A1 Method of inducing homologous recombination of somatic cell |
10/12/2005 | EP1584628A2 Viral protein |
10/12/2005 | EP1583837A1 Targeted transgenesis using the rosa26 locus |
10/12/2005 | EP1583823A2 Isolation and identification of cross-reactive t cells |
10/12/2005 | EP1583503A2 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
10/12/2005 | EP1583424A1 Preparation and administration of hybrid cell vaccines for the prevention of cancer |
10/12/2005 | EP1583422A2 Cell-based therapies for ischemia |
10/12/2005 | EP1530418A4 Methods of identifying and isolating stem cells and cancer stem cells |
10/12/2005 | EP1414379B1 Intrauterine device and method for putting active elements within said device |
10/12/2005 | EP1385936A4 Method for the isolation of stem cells by immuno-labeling with hla/mhc gene product marker |
10/12/2005 | EP1343536B1 Method for decellularising foreign material for the production of bioprostheses |
10/12/2005 | EP1305410B1 Insulin producing cell-line obtained by electrofusion |
10/12/2005 | EP1294918B1 Replication deficient adenoviral tnf vector |
10/12/2005 | EP1137768B1 Human hybrid host cell for mammalian gene expression |
10/12/2005 | EP0669979B1 C-c ckr-1, c-c chemokine receptor |
10/12/2005 | EP0556345B2 Retroviral vectors useful for gene therapy |
10/12/2005 | CN1681931A Use of specific Myb genes for the production of transgenic plants tolerant to biotic and abiotic stresses |